Norway· NO-ID_04B25B3E-0E72-49ED-A4DF-817223F3FC69
Dovprela
A pretomanid product containing pretomanid, registered in Norway by Mylan. The same ATC class is registered in 10 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Pretomanid is registered in 10 of 19 countries.
Countries holding a registration under ATC J04AK08 (pretomanid), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Pretomanid · ATC J04AK08
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Pretomanid
- Manufacturer
- Mylan
- Country
- Norway (NO)
- ATC code
- J04AK08
- ATC class
- Pretomanid
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 2
- no_merkevare_idID_04B25B3E-0E72-49ED-A4DF-817223F3FC69
- no_varenummer29681326
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
20 interactions on record for pretomanid.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pretomanid · interactions on record
20 records
- 9 severe
- 11 moderate
Most severe, free to view
- DexamethasoneH02AB02severe
- DabrafenibL01EC02severe
- LorlatinibL01ED05severe
- DabrafenibL01XE23severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pretomanid in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDOVPRELAMylan IRE Healthcare Limited, Dublin
- FinlandDovprelaMylan IRE Healthcare Limited
- FranceDOVPRELA 200 mg, compriméMYLAN IRE HEALTHCARE (IRLANDE)
- United KingdomDovprela 200mg tabletsImported (Italy)
- IrelandDovprela 200 mg tabletsMylan IRE Healthcare Limited
- IcelandDovprelaMylan IRE Healthcare Limited
- NetherlandsDovprela 200 mg tabletMylan IRE Healthcare Limited
- PolandDovprelaMylan IRE Healthcare Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Dovprela
- Liechtenstein · Dovprela
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ce326098-d00c-4a63-b094-6ae830f81582 GET /v1/drugs/ce326098-d00c-4a63-b094-6ae830f81582?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett",
"source": "fest",
"status": "A",
"atc_name": "Pretomanid",
"merkevare_id": "ID_04B25B3E-0E72-49ED-A4DF-817223F3FC69",
"name_form_strength": "Dovprela tab 200 mg",
"prescription_group": "C"
}See everything about pretomanid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.